Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Yuanheng Pharmaceutical is a comprehensive pharmaceutical enterprise based in Beijing, China, specializing in the research, development, and production of chemical drugs and traditional Chinese medicines (TCM). Established in 2003, the company has developed a diverse product portfolio targeting major therapeutic areas such as cardiovascular health, endocrinology, and gastroenterology. Its commercial offerings include widely used treatments like Amlodipine Besylate for hypertension and Metformin Hydrochloride for diabetes. Yuanheng operates modern, GMP-certified manufacturing facilities and is actively involved in the consistency evaluation of generic drugs to meet international quality standards. The company aims to integrate traditional medical wisdom with modern pharmaceutical technology to provide high-quality healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuanheng Pharmaceutical.